The 'head-to-head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis. [electronic resource]
- Clinical and experimental rheumatology
- 131-9 p. digital
Adolescent Antibodies, Monoclonal--therapeutic use Antirheumatic Agents--therapeutic use Arthritis, Juvenile--drug therapy Child Child, Preschool Etanercept Female Health Status Humans Immunoglobulin G--therapeutic use Infliximab Joints--physiopathology Male Receptors, Tumor Necrosis Factor--therapeutic use Recurrence Remission Induction Retrospective Studies Severity of Illness Index Treatment Outcome